The metastasis-suppressive activity of Nm23-H1 was previously correlated with its in vitro histidine protein kinase activity, but physiological substrates have not been identified. We hypothesized that proteins that interact with histidine kinases throughout evolution may represent partners for Nm23-H1 and focused on the interaction of Arabidopsis "two-component" histidine kinase ERS with CTR1. A mammalian homolog of CTR1 was previously reported to be c-Raf; we now report that CTR1 also exhibits homology to the kinase suppressor of Ras (KSR), a scaffold protein for the mitogen-activated protein kinase (MAPK) cascade. Nm23-H1 co-immunoprecipitated KSR from lysates of transiently transfected 293T cells and at endogenous protein expression levels in MDA-MB-435 breast carcinoma cells. Autophosphorylated recombinant Nm23-H1 phosphorylated KSR in vitro. Phosphoamino acid analysis identified serine as the major target, and two peaks of Nm23-H1 phosphorylation were identified upon high performance liquid chromatography analysis of KSR tryptic peptides. Using site-directed mutagenesis, we found that Nm23-H1 phosphorylated KSR serine 392, a 14-3-3-binding site, as well as serine 434 when serine 392 was mutated. Phosphorylated MAPK but not total MAPK levels were reduced in an nm23-H1 transfectant of MDA-MB-435 cells. The data identify a complex in vitro histidine-to-serine protein kinase pathway, which may contribute to signal transduction and metastasis.Metastasis suppressor genes are credentialed by their ability to suppress metastatic potential in vivo upon injection of a transfected tumor cell line, without a concomitant reduction in primary tumor size (reviewed in Ref. 1). The nm23 gene family was described by its reduced expression in highly metastatic murine melanoma cell lines, as compared with related, tumorigenic but less metastatic cell lines (2) and consists of eight family members (reviewed in Ref.3). In a recent review, 18 of 24 studies found a significant relationship between decreased Nm23 expression in primary human breast carcinomas and an aspect of aggressive clinical course (patient survival, lymph node metastasis, etc.), although Nm23 expression does not represent an independent prognostic or predictive factor (4). Ten transfection experiments have shown that nm23-transfected, metastatically competent cell lines are 40 -98% less metastatic in vivo than control transfectants (5-14). For nm23-H1, the most studied member, overexpression in human MDA-MB-435 breast carcinoma cells reduced colonization in soft agar, both unstimulated and transforming growth factor--stimulated (6), and invasion/motility to a variety of chemoattractants (15-17). Nm23-H1 breast carcinoma transfectants exhibited morphological (ascinus formation) and biosynthetic aspects of differentiation in three-dimensional culture (18), and this finding is supported by similar studies in neural cells (19 -25).Despite extensive work, the biochemical mechanism of action whereby Nm23-H1 suppresses the metastatic potential of cancer cells is unk...